Back22 résultats
GridList
Thumbnail

Oral microbiome’s impact on mucositis and locoregional tumor control in HNSCC patients undergoing radiotherapy

Thumbnail

Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.

Thumbnail

Pembrolizumab plus platinum and taxanes as first-line and as neoadjuvant/induction therapies in PF-unfit patients with PDL1-positive squamous cell carcinoma of the head and neck

Thumbnail

Real world data on Low-Dose Nivolumab with Triple Metronomic Chemotherapy: Retrospective analysis of 50 consecutive patients from LMICs

Thumbnail

Efficacy of nivolumab versus pembrolizumab in rmHNSCC. A prospective national multicenter study.

Thumbnail

Efficacy and Safety of Salvage Chemotherapy After Progression to Anti-PD(L)1 Agents in Patients with Recurrent/Metastatic Head and Neck Cancer

Thumbnail

EFFICACY AND SAFETY OF CHEMO-IMMUNOTHERAPY IN RECURRENT/METASTATIC HNSCC: A RETROSPECTIVE ANALYSIS

Thumbnail

Head and neck re-irradiation: retrospective single institution study of 60 patients treated with curative intention.

Thumbnail

Head and Neck Re-Irradiation: Toxicity Analysis and Correlation between Toxicity and Dosimetric Parametres

Thumbnail

survival outcome of chemotherapy and radiotherapy in patients with metastatic tonsillar cancer(M1)

Thumbnail

Dosimetric evaluation of dysphagia in early stage larynx cancer treated with definitive radiotherapy

Thumbnail

Onco-biota as prognostic factors in Head and Neck Squamous Cell Carcinoma

Thumbnail

“A Retrospective study comparing sequential boost versus integrated boost using volumetric Arc Radiotherapy along with concurrent chemotherapy for Locally Advanced Head and Neck Cancer”.

Thumbnail

Point Of Care Ultrasound (POCUS) in Tracheostomy in Head and Neck Cancer : A Prospective Study.

Thumbnail

Proton arc therapy: advantages over conventional proton therapy and impact on range uncertainties

Thumbnail

Omitting postoperative contralateral radiotherapy in head and neck cancers. A single center report.

Thumbnail

Hypofractionated re-irradiation with Cyberknife for locoregionally recurrent head and neck cancer: a single-center study.

Thumbnail

Evolution of phase 1 clinical trials for head and neck cancer patients based on the experience of a dedicated phase I Unit.

Thumbnail

A novel approach for improving the quality and deliverability of VMAT plans in head and neck cancer

Thumbnail

Long term outcomes of the FiGaRO trial: 18F-FDG-PET in Guided Dose-Painting with Intensity Modulated Radiotherapy in Oropharyngeal Tumours